93 related articles for article (PubMed ID: 30218350)
1. Overexpressed in colorectal carcinoma gene (OCC-1) upregulation and APPL2 gene downregulation in breast cancer specimens.
Ghalaei A; Kay M; Zarrinfam S; Hoseinpour P; Behmanesh M; Soltani BM
Mol Biol Rep; 2018 Dec; 45(6):1889-1895. PubMed ID: 30218350
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of the OCC-1 gene generates three splice variants and a novel exonic microRNA, which regulate the Wnt signaling pathway.
Najafi H; Soltani BM; Dokanehiifard S; Nasiri S; Mowla SJ
RNA; 2017 Jan; 23(1):70-85. PubMed ID: 27986894
[TBL] [Abstract][Full Text] [Related]
3. OCC-1D regulates Wnt signaling pathway: potential role of long noncoding RNA in colorectal cancer.
Yousefi F; Najafi H; Behmanesh M; Soltani BM
Mol Biol Rep; 2022 May; 49(5):3377-3387. PubMed ID: 35397713
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional protein APPL2 contributes to survival of human glioma cells.
Pyrzynska B; Banach-Orlowska M; Teperek-Tkacz M; Miekus K; Drabik G; Majka M; Miaczynska M
Mol Oncol; 2013 Feb; 7(1):67-84. PubMed ID: 22989406
[TBL] [Abstract][Full Text] [Related]
5. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
6. MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line.
Alipoor FJ; Asadi MH; Torkzadeh-Mahani M
J Cell Biochem; 2018 Aug; 119(8):6470-6481. PubMed ID: 29345338
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
8. FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.
Martin BT; Kleiber K; Wixler V; Raab M; Zimmer B; Kaufmann M; Strebhardt K
Cell Cycle; 2007 Jul; 6(14):1779-88. PubMed ID: 17682292
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance.
Liu D; Shi M; Duan C; Chen H; Hu Y; Yang Z; Duan H; Guo N
Mol Immunol; 2013 Nov; 56(1-2):104-12. PubMed ID: 23711387
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
11. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer.
Lan Y; Xiao X; He Z; Luo Y; Wu C; Li L; Song X
Nucleic Acids Res; 2018 Jun; 46(11):5809-5821. PubMed ID: 29931370
[TBL] [Abstract][Full Text] [Related]
13. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.
Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R
Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163
[TBL] [Abstract][Full Text] [Related]
14. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
16. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression.
Canzoneri R; Rabassa ME; Gurruchaga A; Ferretti V; Palma S; Isla-Larrain M; Croce MV; Lacunza E; Abba MC
Oncol Rep; 2018 Aug; 40(2):909-915. PubMed ID: 29901166
[TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
19. PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes.
Singh DK; Gholamalamdari O; Jadaliha M; Ling Li X; Lin YC; Zhang Y; Guang S; Hashemikhabir S; Tiwari S; Zhu YJ; Khan A; Thomas A; Chakraborty A; Macias V; Balla AK; Bhargava R; Janga SC; Ma J; Prasanth SG; Lal A; Prasanth KV
Carcinogenesis; 2017 Oct; 38(10):966-975. PubMed ID: 28633434
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
